Literature DB >> 27157980

Low HIV testing rate and its correlates among men who inject drugs in Iran.

Mostafa Shokoohi1, Mohammad Karamouzian2, Mehdi Osooli3, Hamid Sharifi4, Noushin Fahimfar5, AliAkbar Haghdoost4, Omid Zamani4, Ali Mirzazadeh6.   

Abstract

BACKGROUND: Iran has a concentrated HIV epidemic among people who inject drugs (PWID). Low HIV testing uptake could contribute to the significant number HIV-infected PWID, who go undiagnosed. This study aims to assess HIV testing uptake and its correlates among PWID in Iran.
METHODS: Data were collected through a national cross-sectional bio-behavioral study in 2010. Adult male HIV-negative PWID were included in the current analysis. All estimates were adjusted for the clustering effect of the sampling sites. Multivariable logistic regression was used to examine the correlates of recent HIV testing and adjusted odds ratios (AOR) were reported.
RESULTS: Out of the 2146 eligible PWID for this study, 49.8% reported having ever tested for HIV. However, only 24.9% had tested in the previous year and received their test results. Around 65.2% of PWID knew an HIV testing site. In the multivariable analysis, knowing an HIV testing site (AOR=13.9; P-value<0.001), ≥24 years of age (AOR=3.30; P-value=0.027), and multiple incarcerations (AOR=1.71; P-value<0.001) were positively, and a monthly income of ≥65 US dollar (AOR=0.23; P-value=0.009) was negatively associated with having been tested and received the results.
CONCLUSION: Despite the availability of free HIV counselling and testing for PWID in Iran, only one-fourth of adult male PWID had been tested for HIV and received their results. Implementing policies and strategies to normalize routine HIV testing among PWID are crucial steps to help curb the epidemic among Iranian PWID.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV; HIV testing; Iran; People who inject drug; Surveillance

Mesh:

Year:  2016        PMID: 27157980     DOI: 10.1016/j.drugpo.2016.03.009

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  The HIV treatment cascade in people living with HIV in Iran in 2014: Mixed-method study to measure losses and reasons.

Authors:  Nima Ghalehkhani; Behnam Farhoudi; Mohammad Mehdi Gouya; Hamid Sharifi; SeyedAhmad SeyedAlinaghi; Kianoush Kamali; Noushin Fahimfar; Zahra Rajabpour; Amin Doosti-Irani; Abbas Sedaghat; Ali Mirzazadeh
Journal:  Int J STD AIDS       Date:  2019-09-27       Impact factor: 1.359

2.  Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran.

Authors:  Aryan Esmaeili; Mostafa Shokoohi; Ahmad Danesh; Hamid Sharifi; Mohammad Karamouzian; AliAkbar Haghdoost; Armita Shahesmaeili; Samaneh Akbarpour; Meghan D Morris; Ali Mirzazadeh
Journal:  AIDS Behav       Date:  2019-06

3.  Remaining Gap in HIV Testing Uptake Among Female Sex Workers in Iran.

Authors:  Mostafa Shokoohi; Atefeh Noori; Mohammad Karamouzian; Hamid Sharifi; Razieh Khajehkazemi; Noushin Fahimfar; Samira Hosseini-Hooshyar; Parvin Afsar Kazerooni; Ali Mirzazadeh
Journal:  AIDS Behav       Date:  2017-08

4.  HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.

Authors:  Mohammad Karamouzian; Hamid Sharifi; Mehrdad Khezri; Mostafa Shokoohi; Ali Mirzazadeh; Fatemeh Tavakoli; Nima Ghalekhani; Ghazal Mousavian; Soheil Mehmandoost; Parvin Afsar Kazerooni; Ali Akbar Haghdoost
Journal:  AIDS Behav       Date:  2022-02-23

5.  Estimation of HIV incidence and its trend in three key populations in Iran.

Authors:  Hamid Sharifi; Ali Mirzazadeh; Mostafa Shokoohi; Mohammad Karamouzian; Razieh Khajehkazemi; Soodabeh Navadeh; Noushin Fahimfar; Ahmad Danesh; Mehdi Osooli; Willi McFarland; Mohammad Mehdi Gouya; Ali Akbar Haghdoost
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

6.  Identifying risk factors for late HIV diagnosis and survival analysis of people living with HIV/AIDS in Iran (1987-2016).

Authors:  Younes Mohammadi; Mohammad Mirzaei; Nasrin Shirmohammadi-Khorram; Maryam Farhadian
Journal:  BMC Infect Dis       Date:  2021-04-27       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.